AP324A - Medicaments for treating inflammatory conditions or for analgiesia. - Google Patents

Medicaments for treating inflammatory conditions or for analgiesia. Download PDF

Info

Publication number
AP324A
AP324A APAP/P/1992/000453A AP9200453A AP324A AP 324 A AP324 A AP 324A AP 9200453 A AP9200453 A AP 9200453A AP 324 A AP324 A AP 324A
Authority
AP
ARIPO
Prior art keywords
bismuth citrate
analgesia
inflammatory conditions
treating
steroidal anti
Prior art date
Application number
APAP/P/1992/000453A
Other languages
English (en)
Other versions
AP9200453A0 (en
Inventor
Roger Stables
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919126027A external-priority patent/GB9126027D0/en
Priority claimed from GB929206083A external-priority patent/GB9206083D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AP9200453A0 publication Critical patent/AP9200453A0/xx
Application granted granted Critical
Publication of AP324A publication Critical patent/AP324A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1992/000453A 1991-12-06 1992-12-04 Medicaments for treating inflammatory conditions or for analgiesia. AP324A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126027A GB9126027D0 (en) 1991-12-06 1991-12-06 Medicaments
GB929206083A GB9206083D0 (en) 1992-03-20 1992-03-20 Medicaments

Publications (2)

Publication Number Publication Date
AP9200453A0 AP9200453A0 (en) 1993-01-31
AP324A true AP324A (en) 1994-03-07

Family

ID=26299971

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000453A AP324A (en) 1991-12-06 1992-12-04 Medicaments for treating inflammatory conditions or for analgiesia.

Country Status (26)

Country Link
US (1) US5466436A (it)
EP (1) EP0550083B1 (it)
JP (1) JPH05246853A (it)
KR (1) KR930009605A (it)
AP (1) AP324A (it)
AT (1) AT401468B (it)
AU (1) AU664574B2 (it)
BE (1) BE1007268A3 (it)
CA (1) CA2084568A1 (it)
CH (1) CH685537A5 (it)
CZ (1) CZ358092A3 (it)
DE (1) DE69228738D1 (it)
DK (1) DK0550083T3 (it)
ES (1) ES2130152T3 (it)
FR (1) FR2684554B1 (it)
GB (1) GB2262036B (it)
GR (1) GR3030426T3 (it)
IE (1) IE922866A1 (it)
IL (1) IL103978A (it)
IT (1) IT1256697B (it)
LU (1) LU88196A1 (it)
MX (1) MX9207008A (it)
MY (1) MY108146A (it)
NO (1) NO303670B1 (it)
NZ (1) NZ245365A (it)
PH (1) PH31380A (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As, Oslo Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
HUP9904073A3 (en) * 1996-11-22 2000-04-28 Procter & Gamble Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid
EP0941101A1 (en) * 1996-11-22 1999-09-15 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
PT1411900E (pt) 2001-06-01 2010-10-11 Pozen Inc Composições farmacêuticas para a entrega coordenada de aines
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
NZ565846A (en) * 2005-07-18 2011-12-22 Horizon Therapeutics Inc Medicaments containing famotidine and ibuprofen and administration of same
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
EP2063873A2 (en) * 2006-08-31 2009-06-03 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
AU2009290712A1 (en) 2008-09-09 2010-03-18 Astrazeneca Ab Method for delivering a pharmaceutical composition to patient in need thereof
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
CN110893233A (zh) * 2019-12-19 2020-03-20 川北医学院附属医院 一种鸢尾素在制备抗炎药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105139A (en) * 1981-07-06 1983-03-16 Rca Corp Method and apparatus for operating a microprocessor in synchronism with a video signal
EP0426479A1 (en) * 1989-11-02 1991-05-08 McNEIL-PPC, INC. Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105193B (en) * 1981-09-04 1984-09-12 Glaxo Group Ltd Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
US4757060A (en) * 1986-03-04 1988-07-12 Bristol-Myers Company Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
CH679582A5 (it) * 1988-07-18 1992-03-13 Glaxo Group Ltd
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105139A (en) * 1981-07-06 1983-03-16 Rca Corp Method and apparatus for operating a microprocessor in synchronism with a video signal
EP0426479A1 (en) * 1989-11-02 1991-05-08 McNEIL-PPC, INC. Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence

Also Published As

Publication number Publication date
MY108146A (en) 1996-08-30
GR3030426T3 (en) 1999-09-30
IE922866A1 (en) 1993-06-16
IT1256697B (it) 1995-12-12
AU664574B2 (en) 1995-11-23
IL103978A (en) 1998-06-15
ATA240692A (de) 1996-02-15
ITRM920869A0 (it) 1992-12-04
BE1007268A3 (fr) 1995-05-09
CA2084568A1 (en) 1993-06-07
US5466436A (en) 1995-11-14
ITRM920869A1 (it) 1994-06-04
FR2684554A1 (fr) 1993-06-11
GB2262036A (en) 1993-06-09
NO303670B1 (no) 1998-08-17
GB9225174D0 (en) 1993-01-20
FR2684554B1 (fr) 1995-09-08
AT401468B (de) 1996-09-25
JPH05246853A (ja) 1993-09-24
DE69228738D1 (de) 1999-04-29
ES2130152T3 (es) 1999-07-01
KR930009605A (ko) 1993-06-21
NO924704L (no) 1993-06-07
NZ245365A (en) 1997-06-24
GB2262036B (en) 1996-01-03
EP0550083A1 (en) 1993-07-07
LU88196A1 (fr) 1993-08-17
IL103978A0 (en) 1993-05-13
MX9207008A (es) 1993-06-01
CZ358092A3 (en) 1993-10-13
EP0550083B1 (en) 1999-03-24
DK0550083T3 (da) 1999-10-11
NO924704D0 (no) 1992-12-04
AU2986392A (en) 1993-06-10
CH685537A5 (fr) 1995-08-15
AP9200453A0 (en) 1993-01-31
PH31380A (en) 1998-10-29

Similar Documents

Publication Publication Date Title
AP324A (en) Medicaments for treating inflammatory conditions or for analgiesia.
US4757060A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers
US5037815A (en) Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers
EP0533281B1 (en) The use of ranitidine bismuth citrate and in combination with claritromycin or claritromycin and tetracyclin in the manufacture of a medicament for treating gastrointestinal disorders
FI117373B (fi) Parasetamolia ja domperidonia sisältävä kalvopäällysteinen tabletti
AU692490B2 (en) Methods of inhibiting dysfunctional uterine bleeding
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
US4766117A (en) Antiinflammatory compositions and methods
US8748489B2 (en) Solid pharmaceutical composition containing a combination of an intestinal motility regulating agent and an antiflatulent
RU2108097C1 (ru) Фармацевтическая композиция, содержащая соль ранитидина и карбоксилата висмута, и способ ее получения
JPH08512321A (ja) Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
JPH05509293A (ja) 不整脈および発作の治療における５―ｈｔ４受容体拮抗剤の使用
CA1330306C (en) Medicament for the treatment and prevention of nausea and vomiting
EP0017169B1 (en) Improved anti-inflammatory combinations having reduced ulcerogenicity
GB2216413A (en) Medicaments containing sufotidine
RU2134579C1 (ru) Лекарственные средства для лечения воспалительных состояний или для анальгезии
JPWO2004017954A1 (ja) ジクロフェナクの副作用軽減剤
CA2347192A1 (en) Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine
US4812455A (en) Antiinflammatory compositions and methods
KR20010052895A (ko) 치료 방법
JPH07501076A (ja) 次サリチル酸ビスマスの単位剤形
JP2586922B2 (ja) ある種のｈ▲下１▼およびｈ▲下２▼受容体遮断剤の組合せにより消化管損傷に対して保護された非ステロイド系抗炎症組成物
Maneksha 'Safapryn'and benorylate—a comparative trial of two new preparations of aspirin and paracetamol in the treatment of rheumatoid arthritis and osteoarthritis
JP2007145829A (ja) イブプロフェンを含有する医薬組成物
JPS63250322A (ja) 消化器系疾患治療剤